Table 3.
Quality-of-life median scores at baseline, after 6 weeks, and end of study.
| Baseline
(%, min–max) (n = 9) |
6 weeks
(%, min–max) (n = 8) |
End of study
(%, min–max) (n = 6) |
Reference
value41 |
||
|---|---|---|---|---|---|
| Global quality of life |
83 (50–92) |
67 (33–83) |
58 (0–75) |
78 | |
| Functioning scales: | Physical | 100 (87–100) |
97 (92–100) |
93 (75–100) |
90 |
| Role | 93 (33–100) |
83 (17–100) |
67 (50–100) |
89 | |
| Emotional | 88 (58–100) |
67 (58–100) |
75 (67–92) |
89 | |
| Cognitive | 83 (50–100) |
83 (67–100) |
83 (67–100) |
92 | |
| Social | 75 (33–100) |
67 (33–100) |
100 (67–100) |
94 | |
| Symptom scales: | Fatigue | 28 (0–56) |
39 (11–44) |
22 (11–67) |
17 |
| Vomiting/nausea | 0 (0–83) |
0 (0–33) |
0 (0–17) |
2.7 | |
| Pain | 0 (0–17) |
0 (0–67) |
0 (0–0) |
15 | |
| Single items: | Dyspnea | 0 (0–0) |
0 (0–0) |
0 (0–33) |
7.1 |
| Insomnia | 0 (0–33) |
0 (0–67) |
0 (0–0) |
14 | |
| Appetite loss | 0 (0–67) |
0 (0–33) |
0 (0–67) |
3.3 | |
| Constipation | 0 (0–33) |
33 (0–67) |
0 (0–67) |
4.8 | |
| Diarrhea | 0 (0–33) |
0 (0–33) |
0 (0–33) |
3.9 | |
| Financial difficulties |
0 (0–67) |
0 (0–33) |
0 (0–33) |
3.1 |